Nafarelin (200 mg BID per nasal spray) currently is used as a treatment for mild-to-severe endometriosis. The nurse should tell the woman taking this medication that the drug:
A) Stimulates the secretion of gonadotropin-releasing hormone (GnRH) ,thereby stimulating ovarian activity.
B) Should be sprayed into one nostril every other day.
C) Should be injected into subcutaneous tissue BID.
D) Can cause her to experience some hot flashes and vaginal dryness.
Correct Answer:
Verified
Q1: The two primary areas of risk for
Q1: During her annual gynecologic checkup, a 17-year-old
Q8: With regard to dysfunctional uterine bleeding (DUB),
Q9: When evaluating a client for sexually transmitted
Q10: A woman complains of severe abdominal and
Q14: With regard to dysmenorrhea,nurses should be aware
Q14: Which statement concerning cyclic perimenstrual pain and
Q15: When evaluating a client whose primary complaint
Q17: While interviewing a 31-year-old woman before her
Q18: Management of primary dysmenorrhea often requires a
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents